Clinical trials in Rzeszow – page 26

339 clinical trials in Rzeszow, Poland across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in PolandBadaniaKliniczne.pl

Rzeszow at a glance

339

clinical trials

Research sites4

Quick filters

339 trials in Rzeszow

Open in trial search

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:(Phosphonooxy)Methyln-[(S)-[1-(Bicyclo[1.1.1]Pentan1-Yl)-1H-1,2,3-Triazol-4-Yl](2-Methyl-1-Oxo-1,2-Dihydroisoquinolin-5-Yl)Methyl]-N-{8-Chloro-3-Cyano-4-[(2,2-Dimethylpropyl)Amino]Quinolin-6-Yl]Carbamate
Sponsor:Gilead Sciences Inc.

Contact Research Centre

Osteogenesis imperfecta

Not recruiting

Registered drugNo placebo

Study on the Effects of Romosozumab and Bisphosphonates in Children and Adolescents with Osteogenesis Imperfecta

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Calcium
Sponsor:Amgen Inc.

Contact Research Centre

Eosinophilic gastritis

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Dupilumab for Adults and Adolescents with Eosinophilic Gastritis and Eosinophilic Duodenitis

Registered drug

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Dupilumab
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Acute myocardial infarction

Not recruiting

Registered drug

Study to Test BI 765845 for Patients with Heart Attack

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Bi 765845
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Colitis ulcerative

Not recruiting

Registered drug

Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Moderate to Severe Ulcerative Colitis

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Azathioprine
Sponsor:Janssen Cilag International

Contact Research Centre

Pleural mesothelioma

Not recruiting

Registered drugNo placebo

Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:AstraZeneca AB

Contact Research Centre

Colitis ulcerative

Not recruiting

Registered drugNo placebo

Study on Mirikizumab for Children and Teens with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Mirikizumab
Sponsor:Eli Lilly & Co.

Contact Research Centre

Hormone receptor positive breast cancer+1

Not recruiting

Registered drugNo placebo

Study of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Short stature+3

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Somapacitan for Children with Short Stature Due to Noonan Syndrome, Turner Syndrome, Small for Gestational Age, or Idiopathic Short Stature

InvestigationalNo placebo

Poland

Participants:0–17 years
Substances:Somapacitan
Sponsor:Novo Nordisk A/S

Contact Research Centre

Colitis ulcerative+2

Not recruiting

Registered drugNo placebo

Study on Long-term Safety of Ustekinumab for Children with Crohn's Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Ustekinumab
Sponsor:Janssen Cilag International

Contact Research Centre

Pneumococcal infection

Not recruiting

Registered drug

Study on the V116 Vaccine for Adults Aged 18-64 at Increased Risk of Pneumococcal Infection

Registered drug

Poland

Participants:18–64 years
Substances:Abc-15A-116
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Asthma

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Benralizumab for Children with Severe Eosinophilic Asthma

Registered drug

Poland

Participants:0–17 years
Substances:Benralizumab
Sponsor:AstraZeneca AB

Contact Research Centre

Other cities in Poland

The busiest research cities in the country

All 238 cities in Poland

Clinical research in Rzeszow

What the registry says about research in the country

01 Inflammatory and Autoimmune Conditions

Ongoing research focusing on innovative treatments for inflammatory bowel diseases and autoimmune conditions, including studies on new therapies for ulcerative colitis and Crohn's disease.

Ulcerative Colitis
Crohn's Disease
Psoriasis
Atopic Dermatitis

Multiple trials evaluating novel compounds and biological therapies for inflammatory conditions.

02 Cardiovascular and Metabolic Research

Studies investigating treatments for heart failure prevention and metabolic disorders, with emphasis on innovative therapeutic approaches for obesity and cardiovascular health.

Heart Failure Prevention
Obesity Management
Chronic Kidney Disease

Focus on combination therapies and novel compounds for cardiometabolic conditions.

03 Neurological and Immune System Disorders

Clinical investigations targeting multiple sclerosis and chronic inflammatory conditions affecting the nervous system.

Multiple Sclerosis
CIDP
Immune System Diseases

Evaluation of new therapeutic agents for managing neurological and immune-mediated conditions.

04 Specialized Medical Conditions

Research on various specialized conditions including geographic atrophy and reproductive health treatments.

Age-Related Macular Degeneration
Contraceptive Studies
Pulmonary Conditions

Diverse studies focusing on improving patient outcomes across multiple therapeutic areas.

Back to Poland All countries